Constellation Pharmaceuticals, Inc. CNST
33.99 +33.99
Day range unavailable
52-week range unavailable
Valuation
P/E -10.9×
FY 2016 5y median -3.8× FY 2020
P/S 0.0×
FY 2016 5y median 0.0× FY 2020
P/B 3.3×
FY 2016 5y median 3.3× FY 2020
P/FCF -12.2×
FY 2016 5y median -3.5× FY 2020
EV/EBITDA -9.9×
FY 2016 5y median -3.6× FY 2020
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2020
FCF Yield -8.2%
FY 2016 5y median -28.4% FY 2020
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2020
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2020
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2020
ROE -30.8%
FY 2016 5y median -57.5% FY 2020
ROIC -30.1%
FY 2016 5y median -58.7% FY 2020
ROA -28.6%
FY 2016 5y median -50.4% FY 2020
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2020
Operating Income -45.1%
FY 2016 FY 2020
EPS (diluted) 12.8%
FY 2016 FY 2020
Free Cash Flow -54.0%
FY 2016 FY 2020
Financial Health
Current Ratio 14.0×
FY 2016 5y median 8.0× FY 2020
Quick Ratio 14.0×
FY 2016 5y median 8.0× FY 2020
Debt / Equity 0.0×
FY 2016 5y median 0.1× FY 2020
Net Debt / EBITDA 1.3×
FY 2016 5y median 1.3× FY 2020
Interest Coverage -43.6×
FY 2016 5y median -43.4× FY 2020
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2020
Annual · latest fiscal year ends 2020-12-31
